Reduction of the Renal Radioactivity of 111 In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.3c00258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Hiroyuki Suzuki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-867…. Hauptthemen laut MEDLINE: Radioactivity, Immunoconjugates. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The interposition of a cleavable linkage by enzymes on the renal brush border membrane constitutes a promising approach for reducing the renal radioactivity levels of radiolabeled low-molecular-weight antibody fragments and constructs (LMW Abs). Herein, we applied the molecular design to 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-based reagents for radiotheranostic applications with trivalent radiometals. DOTA or a derivative thereof was conjugated to a Fab through an FGK linkage ([111In]In-DO3AiBu-Bn-FGK-Fab or [111In]In-DOTA-Bn-FGK-Fab). When injected into mice, both generated radiometabolites, [111In]In-DO3AiBu-Bn-F and [111In]In-DOTA-Bn-F, by the angiotensin-converting enzyme at similar rates. Both exhibited significantly lower renal radioactivity levels than a 111In-labeled Fab prepared by the conventional procedure ([111In]In-DOTA-Bn-SCN-Fab). The different elimination rates of each radiometabolite from the kidney significantly affected the renal radioactivity levels. [111In]In-DO3AiBu-Bn-FGK-Fab preferentially reduced the renal localization without impairing tumor accumulation. These findings would pave the way for developing a DOTA-based radiotheranostic platform for LMW Abs bearing cleavable linkers for renal brush border enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.
ORCID-Profile: Hiroyuki Suzuki, Tomoya Uehara, Yasushi Arano
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Suzuki, H., Araki, M., Tatsugi, K., Ichinohe, K., Uehara, T., & Arano, Y. (2023). Reduction of the Renal Radioactivity of 111 In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00258
Vancouver
Suzuki H, Araki M, Tatsugi K, Ichinohe K, Uehara T, Arano Y. Reduction of the Renal Radioactivity of 111 In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00258
BibTeX
@article{Suzuki2023,
author = {Suzuki, Hiroyuki and Araki, Mari and Tatsugi, Kouki and Ichinohe, Kento and Uehara, Tomoya and Arano, Yasushi},
title = {Reduction of the Renal Radioactivity of 111 In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.3c00258}
}
EUVIMED